These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2517020)

  • 21. Potential influences on mathematical difficulties in children and adolescents with neurofibromatosis, type 1.
    Moore BD
    Dev Disabil Res Rev; 2009; 15(1):45-51. PubMed ID: 19213018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Periaqueductal gliosis causing hydrocephalus in a patient with neurofibromatosis type 1.
    Balestrazzi P; de Gressi S; Donadio A; Lenzini S
    Neurofibromatosis; 1989; 2(5-6):322-5. PubMed ID: 2518514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Type 1 neurofibromatosis and epilepsy].
    Boughammoura-Bouatay A; Hizem Y; Chebel S; Frih-Ayed M
    Tunis Med; 2005 Apr; 83(4):243-5. PubMed ID: 15966674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Giant cystic lesion in neurofibromatosis.
    Cohen R; Kornreich L; Shuper A
    Pediatr Neurol; 2009 Dec; 41(6):445-7. PubMed ID: 19931167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Learning disabilities in neurofibromatosis 1: sizing up the brain.
    Gutmann DH
    Arch Neurol; 1999 Nov; 56(11):1322-3. PubMed ID: 10555648
    [No Abstract]   [Full Text] [Related]  

  • 26. Neurobehavioral profiles of children with neurofibromatosis 1 referred for learning disabilities are sex-specific.
    Chapman CA; Waber DP; Bassett N; Urion DK; Korf BR
    Am J Med Genet; 1996 Apr; 67(2):127-32. PubMed ID: 8723038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using magnetic resonance imaging to predict new learning outcome at 5 years after childhood traumatic brain injury.
    Catroppa C; Anderson V; Ditchfield M; Coleman L
    J Child Neurol; 2008 May; 23(5):486-96. PubMed ID: 18184933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diffuse subcortical heterotopias of the gray matter].
    Treguier C; Muh P; Le Berre C; Sorel L; Odent S; Dacher JN; Carsin M
    Pediatrie; 1993; 48(3):223-7. PubMed ID: 8393979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1.
    Leonard JR; Perry A; Rubin JB; King AA; Chicoine MR; Gutmann DH
    Neurology; 2006 Oct; 67(8):1509-12. PubMed ID: 17060590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities.
    North K; Joy P; Yuille D; Cocks N; Mobbs E; Hutchins P; McHugh K; de Silva M
    Neurology; 1994 May; 44(5):878-83. PubMed ID: 8190291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain MRI and proton MRS findings in infants and children with respiratory chain defects.
    Dinopoulos A; Cecil KM; Schapiro MB; Papadimitriou A; Hadjigeorgiou GM; Wong B; deGrauw T; Egelhoff JC
    Neuropediatrics; 2005 Oct; 36(5):290-301. PubMed ID: 16217703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Academic impairment is the most frequent complication of neurofibromatosis type-1 (NF1) in children.
    Coudé FX; Mignot C; Lyonnet S; Munnich A
    Behav Genet; 2006 Sep; 36(5):660-4. PubMed ID: 16474913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurobiological approaches on brains of children with dyslexia: review.
    Caylak E
    Acad Radiol; 2009 Aug; 16(8):1003-24. PubMed ID: 19406674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis.
    Moore BD; Slopis JM; Schomer D; Jackson EF; Levy BM
    Neurology; 1996 Jun; 46(6):1660-8. PubMed ID: 8649566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Von Recklinghausen-neurofibromatosis: a study of the psychological profile.
    Spaepen A; Borghgraef M; Fryns JP
    Birth Defects Orig Artic Ser; 1992; 28(1):85-91. PubMed ID: 1340240
    [No Abstract]   [Full Text] [Related]  

  • 36. Neuronal migration disorders. Part II: Magnetic resonance imaging.
    Saatçi I; Turanli G; Renda Y
    Turk J Pediatr; 1998; 40(4):481-90. PubMed ID: 10028856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I.
    Harting I; Neumaier-Probst E; Seitz A; Maier EM; Assmann B; Baric I; Troncoso M; Mühlhausen C; Zschocke J; Boy NP; Hoffmann GF; Garbade SF; Kölker S
    Brain; 2009 Jul; 132(Pt 7):1764-82. PubMed ID: 19433437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The significance of MRI abnormalities in children with neurofibromatosis.
    Duffner PK; Cohen ME; Seidel FG; Shucard DW
    Neurology; 1989 Mar; 39(3):373-8. PubMed ID: 2494565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive deficits in neurofibromatosis 1.
    North K; Hyman S; Barton B
    J Child Neurol; 2002 Aug; 17(8):605-12; discussion 627-9, 646-51. PubMed ID: 12403559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypopituitarism associated with neurofibromatosis type 1: report of one case.
    Wang CY; Young C; Chu LW; Tsai WY
    Acta Paediatr Taiwan; 2004; 45(1):48-51. PubMed ID: 15264708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.